The key difference is the preservative
Stacked together, patients are usually looking at $400 to $700 per month for both peptides during an active recovery cycle
as for patients with neurological improvement, 1 mg IM OH-Cbl on alternate days until there is no clinical improvement and then maintenance 1 mg IM OH-Cbl every 2 months is recommended ( g low-dose daily oral CN-Cbl is licensed ( In Canada, advice from the British Columbia Medical Association outlines that 1 mg daily oral CN-Cbl should be used for pernicious anemia or food-bound cobalamin malabsorption (FBCM) whereas in most other cases, a daily dose of 250 g may be used ( In Netherlands, controversy arose when the Dutch Organization of General Practitioners published a 2014 viewpoint that 1 mg daily oral OH-Cbl can be utilised as treatment in cases with a cobalamin count below 148 pmol/L and clinical symptoms, with the Dutch B12 Society disputing the efficacy of this and insisting that the advice from the Dutch Healthcare Institute Pharmacotherapeutic Compass should be followed instead (IM/SC starting dose of 10 injections of 1 mg OH-Cbl at intervals of at least 3 days
Chen T-S, Huang T-H, Lai M-C, Huang C-W (2023) The role of glutamate receptors in epilepsy
UNDERSTANDING 5-AMINO-1MQ SIDE EFFECTS AND SAFETY 5 Amino 1MQ Side Effects: What to Expect Current research and clinical observations indicate that 5-amino-1MQ demonstrates a favorable safety profile at recommended dosages
195 medical therapy, and patients who have a complication (eg, toxic megacolon)
